annual SGA:
$62.48M+$31.08M(+98.98%)Summary
- As of today (May 29, 2025), DYN annual SGA is $62.48 million, with the most recent change of +$31.08 million (+98.98%) on December 31, 2024.
- During the last 3 years, DYN annual SGA has risen by +$33.76 million (+117.57%).
- DYN annual SGA is now at all-time high.
Performance
DYN SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$15.93M+$622.00K(+4.06%)Summary
- As of today (May 29, 2025), DYN quarterly SGA is $15.93 million, with the most recent change of +$622.00 thousand (+4.06%) on March 31, 2025.
- Over the past year, DYN quarterly SGA has dropped by -$8.69 million (-35.31%).
- DYN quarterly SGA is now -35.31% below its all-time high of $24.62 million, reached on March 31, 2024.
Performance
DYN quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$3.64B-$367.13M(-11.22%)Summary
- As of today (May 29, 2025), DYN TTM SGA is -$3.64 billion, with the most recent change of -$367.13 million (-11.22%) on March 31, 2025.
- Over the past year, DYN TTM SGA has dropped by -$3.69 billion (-7666.78%).
- DYN TTM SGA is now -18328.36% below its all-time high of -$19.75 million.
Performance
DYN TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
DYN Selling, general & administrative expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +99.0% | -35.3% | -7666.8% |
3 y3 years | +117.6% | +111.0% | -10000.0% |
5 y5 years | +2142.6% | +802.8% | -10000.0% |
DYN Selling, general & administrative expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +121.5% | -35.3% | +161.4% | -353.0% | at low |
5 y | 5-year | at high | +2142.6% | -35.3% | +1087.5% | -6356.5% | at low |
alltime | all time | at high | >+9999.0% | -35.3% | +2361.4% | <-9999.0% | at low |
DYN Selling, general & administrative expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $15.93M(+4.1%) | $53.79M(-13.9%) |
Dec 2024 | $62.48M(+99.0%) | $15.30M(+19.0%) | $62.48M(+11.5%) |
Sep 2024 | - | $12.86M(+32.6%) | $56.02M(+11.6%) |
Jun 2024 | - | $9.70M(-60.6%) | $50.18M(+4.4%) |
Mar 2024 | - | $24.62M(+178.4%) | $48.09M(+53.2%) |
Dec 2023 | $31.40M(+11.3%) | $8.84M(+25.9%) | $31.40M(+6.4%) |
Sep 2023 | - | $7.02M(-7.7%) | $29.51M(-2.0%) |
Jun 2023 | - | $7.61M(-4.1%) | $30.10M(+5.3%) |
Mar 2023 | - | $7.93M(+14.0%) | $28.58M(+1.4%) |
Dec 2022 | $28.20M | $6.96M(-8.6%) | $28.20M(-8.7%) |
Sep 2022 | - | $7.61M(+24.9%) | $30.91M(+4.6%) |
Jun 2022 | - | $6.09M(-19.3%) | $29.55M(-0.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $7.55M(-21.9%) | $29.75M(+3.6%) |
Dec 2021 | $28.72M(+113.6%) | $9.66M(+54.4%) | $28.72M(+12.4%) |
Sep 2021 | - | $6.26M(-0.6%) | $25.56M(+10.4%) |
Jun 2021 | - | $6.29M(-3.3%) | $23.14M(+27.2%) |
Mar 2021 | - | $6.51M(+0.1%) | $18.19M(+35.3%) |
Dec 2020 | $13.45M(+382.7%) | $6.50M(+69.3%) | $13.45M(+64.9%) |
Sep 2020 | - | $3.84M(+186.4%) | $8.16M(+64.4%) |
Jun 2020 | - | $1.34M(-24.0%) | $4.96M(+37.0%) |
Mar 2020 | - | $1.76M(+45.7%) | $3.62M(+94.9%) |
Dec 2019 | $2.79M(+438.9%) | $1.21M(+87.2%) | $1.86M(+187.2%) |
Sep 2019 | - | $647.00K | $647.00K |
Dec 2018 | $517.00K | - | - |
FAQ
- What is Dyne Therapeutics annual SGA?
- What is the all time high annual SGA for Dyne Therapeutics?
- What is Dyne Therapeutics annual SGA year-on-year change?
- What is Dyne Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly SGA year-on-year change?
- What is Dyne Therapeutics TTM SGA?
- What is the all time high TTM SGA for Dyne Therapeutics?
- What is Dyne Therapeutics TTM SGA year-on-year change?
What is Dyne Therapeutics annual SGA?
The current annual SGA of DYN is $62.48M
What is the all time high annual SGA for Dyne Therapeutics?
Dyne Therapeutics all-time high annual SGA is $62.48M
What is Dyne Therapeutics annual SGA year-on-year change?
Over the past year, DYN annual SGA has changed by +$31.08M (+98.98%)
What is Dyne Therapeutics quarterly SGA?
The current quarterly SGA of DYN is $15.93M
What is the all time high quarterly SGA for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly SGA is $24.62M
What is Dyne Therapeutics quarterly SGA year-on-year change?
Over the past year, DYN quarterly SGA has changed by -$8.69M (-35.31%)
What is Dyne Therapeutics TTM SGA?
The current TTM SGA of DYN is -$3.64B
What is the all time high TTM SGA for Dyne Therapeutics?
Dyne Therapeutics all-time high TTM SGA is -$19.75M
What is Dyne Therapeutics TTM SGA year-on-year change?
Over the past year, DYN TTM SGA has changed by -$3.69B (-7666.78%)